These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 11193214

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
    Veugelers M, Cat BD, Muyldermans SY, Reekmans G, Delande N, Frints S, Legius E, Fryns JP, Schrander-Stumpel C, Weidle B, Magdalena N, David G.
    Hum Mol Genet; 2000 May 22; 9(9):1321-8. PubMed ID: 10814714
    [Abstract] [Full Text] [Related]

  • 4. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
    Veugelers M, Vermeesch J, Watanabe K, Yamaguchi Y, Marynen P, David G.
    Genomics; 1998 Oct 01; 53(1):1-11. PubMed ID: 9787072
    [Abstract] [Full Text] [Related]

  • 5. Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome.
    Pellegrini M, Pilia G, Pantano S, Lucchini F, Uda M, Fumi M, Cao A, Schlessinger D, Forabosco A.
    Dev Dyn; 1998 Dec 01; 213(4):431-9. PubMed ID: 9853964
    [Abstract] [Full Text] [Related]

  • 6. Glypican-3 expression is silenced in human breast cancer.
    Xiang YY, Ladeda V, Filmus J.
    Oncogene; 2001 Nov 01; 20(50):7408-12. PubMed ID: 11704870
    [Abstract] [Full Text] [Related]

  • 7. Expression of glypican 3 in placental site trophoblastic tumor.
    Ou-Yang RJ, Hui P, Yang XJ, Zynger DL.
    Diagn Pathol; 2010 Sep 25; 5():64. PubMed ID: 20868507
    [Abstract] [Full Text] [Related]

  • 8. Glypican 3 and glypican 4 are juxtaposed in Xq26.1.
    Huber R, Mazzarella R, Chen CN, Chen E, Ireland M, Lindsay S, Pilia G, Crisponi L.
    Gene; 1998 Dec 28; 225(1-2):9-16. PubMed ID: 9931407
    [Abstract] [Full Text] [Related]

  • 9. Fibroblast growth factor-2 and fibroblast growth factor receptor-1 mRNA expression and peptide localization in placentae from normal and diabetic pregnancies.
    Arany E, Hill DJ.
    Placenta; 1998 Dec 28; 19(2-3):133-42. PubMed ID: 9548179
    [Abstract] [Full Text] [Related]

  • 10. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
    Murthy SS, Shen T, De Rienzo A, Lee WC, Ferriola PC, Jhanwar SC, Mossman BT, Filmus J, Testa JR.
    Oncogene; 2000 Jan 20; 19(3):410-6. PubMed ID: 10656689
    [Abstract] [Full Text] [Related]

  • 11. SIMPSON-GOLABI-BEHMEL syndrome type 1: How placental immunohistochemistry can rapidly Predict the diagnosis.
    Fiandrino G, Arossa A, Ghirardello S, Kalantari S, Rossi C, Bonasoni MP, Cesari S, Rizzuti T, Giorgio E, Bassanese F, Scatigno AL, Meroni A, Melito C, Feltri M, Longo S, Figar TA, Andorno A, Gelli MC, Bertozzi M, Spinillo A, Riccipetitoni G, Valente EM, Paulli M, Sirchia F.
    Placenta; 2022 Aug 20; 126():119-124. PubMed ID: 35796063
    [Abstract] [Full Text] [Related]

  • 12. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.
    Gonzalez AD, Kaya M, Shi W, Song H, Testa JR, Penn LZ, Filmus J.
    J Cell Biol; 1998 Jun 15; 141(6):1407-14. PubMed ID: 9628896
    [Abstract] [Full Text] [Related]

  • 13. Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface.
    Jokhi PP, Chumbley G, King A, Gardner L, Loke YW.
    Lab Invest; 1993 Mar 15; 68(3):308-20. PubMed ID: 8450649
    [Abstract] [Full Text] [Related]

  • 14. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
    Lin H, Huber R, Schlessinger D, Morin PJ.
    Cancer Res; 1999 Feb 15; 59(4):807-10. PubMed ID: 10029067
    [Abstract] [Full Text] [Related]

  • 15. Expression of glypican 3 (GPC3) in embryonal tumors.
    Saikali Z, Sinnett D.
    Int J Cancer; 2000 Sep 20; 89(5):418-22. PubMed ID: 11008203
    [Abstract] [Full Text] [Related]

  • 16. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
    Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J.
    J Cell Biol; 1999 Jul 12; 146(1):255-64. PubMed ID: 10402475
    [Abstract] [Full Text] [Related]

  • 17. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
    Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H.
    Int J Cancer; 2003 Feb 10; 103(4):455-65. PubMed ID: 12478660
    [Abstract] [Full Text] [Related]

  • 18. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome.
    Li M, Shuman C, Fei YL, Cutiongco E, Bender HA, Stevens C, Wilkins-Haug L, Day-Salvatore D, Yong SL, Geraghty MT, Squire J, Weksberg R.
    Am J Med Genet; 2001 Aug 01; 102(2):161-8. PubMed ID: 11477610
    [Abstract] [Full Text] [Related]

  • 19. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
    Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A.
    Dev Biol; 2002 Mar 01; 243(1):185-206. PubMed ID: 11846487
    [Abstract] [Full Text] [Related]

  • 20. Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest.
    Farooq M, Hwang SY, Park MK, Kim JC, Kim MK, Sung YK.
    Mol Cells; 2003 Jun 30; 15(3):356-60. PubMed ID: 12872992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.